David Mikos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Mikos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Mikos Today - Breaking & Trending Today

Distinct Toxicity Profiles for Anti-BCMA Myeloma Therapies

Published: December 12, 2023

CAR T cells directed against the B-cell maturation antigen (BCMA) are linked to systemic and neurological side effects, while the antibody teclistamab is associated with increased infection risk.

Source: medscape.com

Related Topics:

United StatesDavid MiklosZimu GongDavid MikosStanford UniversityCancer Center At Houston Methodist HospitalAmerican Society Of HematologyCancer CenterHouston MethodistAmerican SocietyEvent Reporting SystemMedscape Medical NewsMultiple MyelomaPlasma Cell MyelomaBiologic TherapyChimeric Antigen Receptort Cell TherapyChimeric Antigen ReceptorsHimeric ImmunoreceptorsHimerict Cell ReceptorsRtificialt Cell ReceptorsArt Chimaeric Antigen Receptort Cell Therapy Receptors Immunoreceptors Chimaerict